[HTML][HTML] Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms

G Meola, R Cardani - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2015 - Elsevier
Myotonic dystrophy (DM) is the most common adult muscular dystrophy, characterized by
autosomal dominant progressive myopathy, myotonia and multiorgan involvement. To date …

MBNL proteins and their target RNAs, interaction and splicing regulation

P Konieczny, E Stepniak-Konieczna… - Nucleic acids …, 2014 - academic.oup.com
Muscleblind-like (MBNL) proteins are key regulators of precursor and mature mRNA
metabolism in mammals. Based on published and novel data, we explore models of tissue …

Aerobic exercise elicits clinical adaptations in myotonic dystrophy type 1 patients independently of pathophysiological changes

AI Mikhail, PL Nagy, K Manta, N Rouse… - The Journal of …, 2022 - Am Soc Clin Investig
Background Myotonic dystrophy type 1 (DM1) is a complex life-limiting neuromuscular
disorder characterized by severe skeletal muscle atrophy, weakness, and cardiorespiratory …

[HTML][HTML] Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies

G Meola - Acta Myologica, 2013 - ncbi.nlm.nih.gov
Myotonic dystrophy (DM) is the most common adult muscular dystrophy, characterized by
autosomal dominant progressive myopathy, myotonia and multiorgan involvement. To date …

Competition between RNA-binding proteins CELF1 and HuR modulates MYC translation and intestinal epithelium renewal

L Liu, M Ouyang, JN Rao, T Zou, L Xiao… - Molecular biology of …, 2015 - Am Soc Cell Biol
The mammalian intestinal epithelium is one of the most rapidly self-renewing tissues in the
body, and its integrity is preserved through strict regulation. The RNA-binding protein (RBP) …

[HTML][HTML] Myotonic dystrophy type 2: the 2020 update

G Meola - Acta Myologica, 2020 - ncbi.nlm.nih.gov
The myotonic dystrophies are the commonest cause of adult-onset muscular dystrophy.
Phenotypes of DM1 and DM2 are similar, but there are some important differences …

[HTML][HTML] Myotonic dystrophies: targeting therapies for multisystem disease

S LoRusso, B Weiner, WD Arnold - Neurotherapeutics, 2018 - Elsevier
Myotonic dystrophy is an autosomal dominant muscular dystrophy not only associated with
muscle weakness, atrophy, and myotonia but also prominent multisystem involvement …

rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences

C Sellier, E Cerro-Herreros, M Blatter… - Nature …, 2018 - nature.com
Myotonic dystrophy type 1 and type 2 (DM1, DM2) are caused by expansions of CTG and
CCTG repeats, respectively. RNAs containing expanded CUG or CCUG repeats interfere …

Myotonic dystrophy type 2: an update on clinical aspects, genetic and pathomolecular mechanism

G Meola, R Cardani - Journal of neuromuscular diseases, 2015 - content.iospress.com
Myotonic dystrophy (DM) is the most common adult muscular dystrophy, characterized by
autosomal dominant progressive myopathy, myotonia and multiorgan involvement. To date …

Relation of genomic variants for Alzheimer disease dementia to common neuropathologies

JM Farfel, L Yu, AS Buchman, JA Schneider… - Neurology, 2016 - AAN Enterprises
Objective: To investigate the associations of previously reported Alzheimer disease (AD)
dementia genomic variants with common neuropathologies. Methods: This is a postmortem …